Katy Perry's upcoming world tour has generated concern among fans and critics alike as ticket sales become a hot topic of conversation. Despite rumors of disappointing sales, which were first reported by The U.S. Sun, no dates are expected to be canceled. In fact, Perry announced additional nights in some locations to accommodate fan demand. The pop star is set to launch her major Lifetimes tour in Mexico City on April 23, 2025.
The ambitious 83-date tour will span North America, South America, Europe, and Australia, concluding in Madrid on November 11, 2025. Joining Perry on her tour will be singer Rebecca Black, perhaps in a nod to the younger segment of Perry's fan base.
Perry recently expressed excitement about the tour, stating, "It's gonna be big!" However, insiders have indicated mixed feelings about ticket sales. A source told The U.S. Sun, "Expectations were high, and she is disappointed by the lack of interest in some countries and venues. Some people involved thought it would be a massive wave with ticket sales exploding quickly, but sadly she is not Taylor Swift. It's starting to get very concerning, as we need those big dates to be full.”
As of last month, around 70% of tickets for her May 13 show in Minneapolis remained unsold, while 60% of seats were still available in Raleigh, North Carolina. However, there is still time for the sales numbers to improve as some shows are several months away.
In contrast, there have been reports of extra nights being added in other locations, reflecting a surge in demand. This disparity in ticket sales highlights the fluctuating nature of concert attendance, particularly as fans eagerly await their chance to see Perry perform.
Interestingly, it seems Perry has taken inspiration from fellow pop star Taylor Swift and her recent Eras Tour, which has been hailed as the Tour of the Century at the iHeartRadio Music Awards. A source mentioned, "Katy saw one of Taylor's shows last year and was excited and inspired by what she saw. She knows she can count on her to give her some positive feedback. Taylor wants Katy to succeed and have a great tour, and enjoy her time while on the road, and Katy appreciates that." This mutual support among artists is refreshing and might help bolster Perry's confidence as she embarks on her tour journey.
However, Perry's return to the touring scene hasn't come without a touch of controversy. Last summer, she released her single “Woman's World,” produced by Dr. Luke, who remains a controversial figure in the industry. Many fans were quick to voice their concerns online, with one commenting, "The irony of having a song praising women but you're working with Dr. Luke? Katy Perry, I didn't expect this from you."
Dr. Luke faced serious allegations of sexual assault made by singer Kesha, which he has consistently denied. Their long legal battle recently ended in a settlement in 2023 after he sued Kesha for defamation, leaving a significant mark on both their careers.
Actress Abigail Breslin also weighed in on the controversy, stating, "I'm just saying... working with known abusers in any industry just contributes to the narrative that men can do abhorrent shit and get away with it." Such criticism adds another layer of complexity to Perry’s upcoming tour and could impact her public perception.
While ticket sales may pose a challenge, it’s clear that Katy Perry is determined to move forward with her Lifetimes tour, backed by her willingness to expand shows based on demand and draw inspiration from fellow artists. As fans gear up for the performances, only time will tell how successful this new endeavor will be.
In summary, despite the initial concerns over disappointing ticket sales, Perry's team remains optimistic. With the addition of new shows to meet demand in some areas, there’s a balancing act between high expectations and the realities of the concert industry. Whatever the outcome may be, Katy Perry's Lifetimes tour is set to be a significant moment in her career as she navigates the landscape of current pop culture while addressing past controversies.